(19)
(11) EP 4 558 122 A1

(12)

(43) Date of publication:
28.05.2025 Bulletin 2025/22

(21) Application number: 23742463.5

(22) Date of filing: 06.07.2023
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 38/13(2006.01)
A61K 47/44(2017.01)
A61K 9/10(2006.01)
A61K 47/10(2017.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/13; A61K 9/0048; A61K 9/1075; A61K 47/10; A61K 47/44
(86) International application number:
PCT/IL2023/050699
(87) International publication number:
WO 2024/018450 (25.01.2024 Gazette 2024/04)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 20.07.2022 IL 29489622

(71) Applicant: Lyotropic Delivery Systems Ltd.
9139002 Jerusalem (IL)

(72) Inventors:
  • GARTI, Nissim
    4723127 Ramat HaSharon (IL)
  • GARTI-LEVI, Sharon
    7173871 Modi'in (IL)
  • EDRI, Rotem
    8826222 Eilat (IL)
  • MUSLEH, Rawan
    94007 94007 Jerusalem (IL)

(74) Representative: HGF 
HGF Limited 1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB)

   


(54) TOPICAL OCULAR DELIVERY OF CYCLOSPORIN